Skip to content

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05701020
Acronym
EVASEF
Enrollment
90
Registered
2023-01-27
Start date
2022-12-13
Completion date
2023-09-12
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidemiology, Sexual Dysfunction

Keywords

Abnormal pap test, Sexual Dysfunction, Epidemiology

Brief summary

Human Papilloma virus is the most common sexual infection in women, which can leads to cervical lesion and cervical cancer. Pap test is recommanded in women of 25 years old until 65 years old in order to screen subclinic lesions and improve prognosis. Yet, scientific knowledge about chronic disease showed negative consequences on quality of life. However, no study until now has striven to evaluate the consequences of an abnormal pap test on sexuality in adult women. The aim of this study is to evaluate if an abnormal pap test have an impact on the sexual functions in women because of the anxiety and psychological consequences of the diagnosis

Interventions

If agreeing to the protocol, ; patients will answered questions about sexual health during the gynecologic consultation

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult women with an abnormal pap test. * Diagnosis known 4 to 12 weeks before the appointment for colposcopy

Exclusion criteria

* Cervical cancer * Pregnancy

Design outcomes

Primary

MeasureTime frame
% ofpositive response rate at the first question of the questionnaire18 months

Secondary

MeasureTime frame
Number of causes of woman alteration sexual function alteration18 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026